Mevim S.p.A. (BIT:MEV)
Italy flag Italy · Delayed Price · Currency is EUR
0.4010
-0.0100 (-2.43%)
At close: Aug 12, 2025, 5:30 PM CET

Aerovate Therapeutics Revenue

In the year 2024, Mevim had annual revenue of 5.81M EUR with 5.29% growth. Mevim had revenue of 3.13M in the half year ending December 31, 2024, a decrease of -1.30%.

Revenue
5.81M
Revenue Growth
+5.29%
P/S Ratio
0.32
Revenue / Employee
387.19K
Employees
15
Market Cap
1.86M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.81M291.74K5.29%
Dec 31, 20235.52M795.71K16.86%
Dec 31, 20224.72M1.90M67.42%
Dec 31, 20212.82M1.36M92.70%
Dec 31, 20201.46M-1.08M-42.46%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UniCredit24.82B
Intesa Sanpaolo25.58B
Enel SpA77.79B
Ferrari6.96B
Assicurazioni Generali56.77B
Eni S.p.A.87.03B
Leonardo S.p.a.18.70B
Poste Italiane13.75B
Revenue Rankings